Michael Robert Martin, Chief Business Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 45,000 shares at $31.64 ($1.4M) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $1.4M AUPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AUPH | SELL | 2021-11-12 | $4.5M | — | Filing → |
| AUPH | SELL | 2021-09-22 | $2.7M | — | Filing → |
| AUPH | SELL | 2021-09-16 | $958K | — | Filing → |